A new biotech startup tries to tackle obesity, but not in the way you might expect

A new startup is making a bold move in the world of obesity drug development: It’s not working with the GLP-1 target that has ...

New Haven poised to advance 200,000-square-foot Unilever lab as Downtown Crossing nears final phase

The project's development and land disposition agreements will go before the Board of Alders' Community Development Committee during a public hearing at 6 p.m. Wednesday.

HealthKois eyes biotech bets as new drug pipelines expand

A joint report launched by HealthKois and BCG on Wednesday stated that PE/VC investment into pharma rose 2.1x in five years ...